Starpharma Pty Ltd

DEP

Polyvalent compounds, polymers and dendrimers sold as a component part of pharmaceutical preparations for use in the treatment of cancer, inflammation, metabolic disorders, hematological disorders, endocrine disorders and infectious diseases; drug delivery agents consisting of polymers that facilitate delivery of a wide range of therapeutic agents;Research and development of chemical and biological compounds for medical, veterinary and diagnostic purposes;

VIRALEZE

Antiviral pharmaceutical preparations; pharmaceutical preparations to reduce or prevent acquisition and transmission of viral infection; pharmaceutical preparations for prevention of coronavirus infection and transmission; pharmaceutical preparations to inactivate coronavirus; Pharmaceutical preparations for nasal use for the treatment and prevention of viral infections; Medicated nasal spray, drops and washes for the treatment and prevention of viral infections; Inhalation preparations for the treatment and prevention of viral disease; Pharmaceutical preparations for oral use for the treatment and prevention of viral infections; Medicated preparations for oral hygiene, other than dentifrices; Medicated antimicrobial mouthwashes; Medicated lozenges; Medicated Eye drops, sprays gels and washes; Medicated topical preparations for the eyes for the treatment and prevention of viral infections; Antiviral skin gels; Kit comprising sanitary mask and antiviral preparation for disease prevention, namely, for the prevention of viral infection;Inserts specially adapted for use with sanitary protective breathing masks for medical purposes; Protective masks for surgical, medical, dental use;

VIVAGEL

Pharmaceuticals, pharmaceutical preparations, and drugs for medical purposes for treatment and prevention of [ viral, ] fungal and bacterial disease, namely, bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), human immunodeficiency virus (HIV)] ; [ chemical and biological preparations, ] substances for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) ] ; [ reagents and ] compounds for medical purposes; polyvalent compounds, synthetic molecules and dendrimers for medical purposes for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) ] ; antimicrobial preparations, namely, microbicidal preparations in the nature of gels [, foams, creams, films, solutions, suppositories, suspensions and lotions ] for vaginal [, rectal and transdermal ] use for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); contraceptives, namely, oral contraceptives, sponges, gels, foams, creams, films, solutions, suppositories, suspensions and lotions for use in preventing HIV and other sexually transmitted infections ] ; prophylactic preparations for prevention of [ pregnancy and ] disease; gels [, foams, creams, films, solutions, suppositories, suspensions and lotions, ] for the treatment of [ viral, fungal and ] bacterial diseases, namely, bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of human immunodeficiency virus ] ; vaginal gels [ and lubricants ] for the prevention of [ pregnancy and sexually transmitted infections and ] diseases of the human reproductive system;VIVA GEL;[ Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices ];

VIVAGEL

In the statement, Page 1, line 38, FILED 10-27-2016 should be deleted, and FILED 5-02-2016 should be inserted.;Pharmaceuticals, pharmaceutical preparations, and pharmaceutical drugs for medical purposes for prevention of viral and bacterial disease, namely, bacterial vaginosis, herpes simplex virus, human papilloma virus, and human immunodeficiency virus (HIV); chemical preparations for pharmaceutical and medical purposes for the prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus and human immunodeficiency virus (HIV); chemical compounds in the nature of antimicrobial or ph balancing or microbial balancing substances all for medical purposes, namely, for treating and preventing vaginal microbial imbalance, vaginal pH imbalance, vaginal odor and discharge, bacterial vaginosis, viral STD, vaginaitis, vaginal thrush, vaginal disease symptom relief including itching, odor, and discharge, for maintaining a healthy balance of vaginal flora and for the reestablishment of the bacterial vaginal flora; polyvalent compounds and dendrimers sold as integral component parts of pharmaceuticals preparations all for medical purposes for the treatment and prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); antimicrobial preparations, namely, microbicidal preparations in the nature of gels, films, solutions, lubricants for vaginal and rectal use for prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); chemical contraceptives, namely, sponges, gels, foams, creams, films, solutions, suspensions and lotions for use in preventing HIV and other sexually transmitted infections; prophylactic preparations for prevention of pregnancy and microbial disease of the reproductive system, namely, chemical contraceptives and antibacterial preparations in the nature of sponges, suppositories, sexual lubricants, gels, foams, creams, films, solutions, suspensions and lotions; pharmaceutical preparations in the nature of vaginal gels and lubricants all for the prevention of pregnancy and sexually transmitted infections and diseases of the human reproductive system;VIVA GEL;The English translation of VIVA in the mark is LIVE or LONG LIFE. The wording VIVAGEL has no meaning in a foreign language.;Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices;